Akero Therapeutics
Price & Volume
Stats
See more52W Range | $15.32-$37 |
Market Cap | $2B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.78 |
News
See moreYahoo Finance • 7 months ago
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Yahoo Finance • 7 months ago
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Yahoo Finance • 8 months ago
Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
Yahoo Finance • last year
Akero Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
About
CEO | Dr. Andrew Cheng M.D., Ph.D. |
CFO | Mr. William R. White J.D. |
Address | 601 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 60 |
